From Monday Magazine (BC):
The nine members of the provincial government’s new pharmaceutical task force include the head of Canada’s largest drug lobby group, but nobody to represent the interests of patients or the public.
“It’s a good idea to do this, but the compostion of the board is highly debateable,” says Adrian Dix, the NDP health critic. “I think it’s extraordinary and bizarre the pharmaceutical representatives were put on the panel this way. It’s really unfortunate patients are so poorly represented here.”
The highest profile drug industry representative on the task force is Russell Williams, the president of Canada’s Research-based Pharmaceutical Companies (Rx&D), a national lobby group with members from some 50 drug companies and whose directors include the presidents, CEOs and other top officials from 14 of the countries biggest drug manufacturers. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment